Oncology Today with Dr Neil Love cover image

Management of HER2-Altered Non-Small Cell Lung Cancer

Oncology Today with Dr Neil Love

00:00

Trastuzumab in Breast Cancer - What's Your Vision?

Trastuzumab is naked antibody without the warhead. So it's a missile, but it doesn't have the bomb. What it does is it's got multiple mechanisms of action. It certainly has a signal inhibition capability. And that will localize the enemy with HER2 and then elicit these antibody responses that are cell-mediated.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app